Abstract

NANOSTRUCTURED LIPID CARRIERS: A POTENTIAL DRUG CARRIER FOR CANCER CHEMOTHERAPY

Mr. Omkar M. Lakhotiya* and Proof. Santosh Waghmare

.

Abstract

With the exponential growth of nanotechnology, the focus has been on medicinal endeavours, particularly for chemotherapy for cancer. As alternative carriers for pharmaceutical consignments, notably anticancer medicines, nanostructured lipid carriers have gained growing scientific and commercial attention in recent years. Anticancer mixtures frequently have drawbacks such as poor solubility, normal tissue toxicity, poor specificity, and instability, as well as a high incidence rate of drug resistance and rapid degradation, the requirement for large-scale output procedures, a rapid release of the drug from its carrier scheme, stability issues, the presence of leftover organic solvents from the output method, and the toxicity of the polymer with respect to the car. The advantages, varieties, drug release modulations, steadiness, and output approaches of NLCs are covered in this review. Additionally, the role of NLC in cancer treatment is discussed, and research hotspots are highlighted.

Keywords: .